ClinicalTrials.Veeva

Menu

Evaluation of Circadian OS Technology on Melatonin Suppression

Mount Sinai Health System logo

Mount Sinai Health System

Status

Completed

Conditions

Circadian Disruption

Treatments

Device: Circadian OS software

Study type

Interventional

Funder types

Other

Identifiers

NCT07095270
STUDY-24-00822

Details and patient eligibility

About

Primary Objective: Evaluate how the Circadian OS iPad-based light intervention suppresses melatonin. This small pilot study is designed to validate the Circadian OS technology by testing physiological response using melatonin suppression. The study aims to evaluate how the Circadian OS iPad-based light intervention influences sleepiness as measured objectively via suppression of melatonin and subjectively via the Karolinska Sleepiness scale.

Full description

Aims: To test whether the Circadian OS app delivers sufficient circadian effective light that will result in measurable melatonin suppression (target suppression is 30% after 1 hour exposure)

Hypothesis: The Circadian OS app will deliver a Circadian Stimulus (CS) of 0.3 at the eye level and will result in 30% melatonin suppression after one hour using the device compared to less than 10% suppression without the Circadian OS app and the subjects will feel less sleepy (KSS score) when exposed to the Circadian OS app compared to no app

Outcomes: melatonin suppression will be calculated from saliva samples and subjective sleepiness as self-rated on the Karolinska Sleepiness Scale (KSS)

Enrollment

10 patients

Sex

All

Ages

30 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

• Healthy adults over the age of 30

Exclusion criteria

  • Use of over-the-counter melatonin or prescription medications
  • Obstructing cataracts, macular degeneration, or blindness
  • Heart disease or high blood pressure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

10 participants in 2 patient groups, including a placebo group

Active Condition - iPad with Circadian OS App
Active Comparator group
Description:
iPad with Circadian OS App ON - iPad screen brightness adjusted by Circadian OS software to provide circadian-effective light exposure.
Treatment:
Device: Circadian OS software
Control Condition
Placebo Comparator group
Description:
iPad with Circadian OS App OFF and iPad screen dimmed to lowest setting
Treatment:
Device: Circadian OS software

Trial contacts and locations

1

Loading...

Central trial contact

Barbara Plitnick

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems